Literature DB >> 6433328

The distribution and origin of VIP in the spinal cord of six mammalian species.

S J Gibson, J M Polak, P Anand, M A Blank, J F Morrison, J S Kelly, S R Bloom.   

Abstract

The distribution of VIP-immunoreactivity was studied in the spinal cord and dorsal root ganglia of 6 mammalian species. Immunoreactive fibres and cell bodies were most apparent in the dorsal horn, dorsolateral funiculus, intermediolateral cell columns and the area around the central canal. The distribution of VIP immunoreactivity was similar in all species studied, mouse, rat, guinea pig, cat, horse and the marmoset monkey. There were fewer VIP fibres in the dorsal horn of cervical and thoracic segments than in lumbosacral segments. Using radioimmunoassay this gradient increase was quantitatively most marked in the sacral spinal cord of the cat. In dorsal root ganglia few nerve cell bodies but numerous fibres were present. A dual origin for VIP in the spinal cord is suggested: (A) Extrinsic, from dorsal root afferent fibres since immunoreactivity was decreased in dorsally rhizotomized animals (cats and rats) and in capsaicin pretreated rats (microinjection of dorsal root ganglia). (B) From local cell bodies intrinsic to the spinal cord which became visible after colchicine pretreatment of rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6433328     DOI: 10.1016/0196-9781(84)90207-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  Phenotypic diversity and expression of GABAergic inhibitory interneurons during postnatal development in lumbar spinal cord of glutamic acid decarboxylase 67-green fluorescent protein mice.

Authors:  K J Dougherty; M A Sawchuk; S Hochman
Journal:  Neuroscience       Date:  2009-06-26       Impact factor: 3.590

2.  A large proportion of afferent neurons innervating the uterine cervix of the cat contain VIP and other neuropeptides.

Authors:  M Kawatani; W C de Groat
Journal:  Cell Tissue Res       Date:  1991-10       Impact factor: 5.249

3.  Vasoactive intestinal polypeptide increases in areas of the dorsal horn of the spinal cord from which other neuropeptides are depleted following peripheral axotomy.

Authors:  S A Shehab; M E Atkinson
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

Review 4.  Regulatory peptide immunocytochemistry at light- and electron microscopical levels.

Authors:  S Van Noorden; I A Varndell
Journal:  Experientia       Date:  1987-07-15

5.  Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves.

Authors:  C H Hoyle; R W Stones; T Robson; K Whitley; G Burnstock
Journal:  J Anat       Date:  1996-06       Impact factor: 2.610

6.  The immunocytochemical distribution of seven peptides in the spinal cord and dorsal root ganglia of horse and pig.

Authors:  A Merighi; S Kar; S J Gibson; S Ghidella; A Gobetto; S M Peirone; J M Polak
Journal:  Anat Embryol (Berl)       Date:  1990

Review 7.  The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide in the neural pathways controlling the lower urinary tract.

Authors:  Mitsuharu Yoshiyama; William C de Groat
Journal:  J Mol Neurosci       Date:  2008-08-02       Impact factor: 3.444

Review 8.  Neuropeptides in pelvic afferent pathways.

Authors:  W C de Groat
Journal:  Experientia       Date:  1987-07-15

9.  Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells.

Authors:  G Ju; T Hökfelt; E Brodin; J Fahrenkrug; J A Fischer; P Frey; R P Elde; J C Brown
Journal:  Cell Tissue Res       Date:  1987-02       Impact factor: 5.249

Review 10.  Therapeutic potential of neuropeptide Y (NPY) receptor ligands.

Authors:  Shaun P Brothers; Claes Wahlestedt
Journal:  EMBO Mol Med       Date:  2010-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.